Frexalimab Has Favorable Effect on Relapsing Multiple Sclerosis

WEDNESDAY, Feb. 14, 2024 -- For patients with relapsing multiple sclerosis, the anti-CD40L monoclonal antibody frexalimab has a favorable effect on the number of new gadolinium-enhancing T1-weighted lesions, according to a study published in the...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news